BR0308027A - Processo para preparação de um derivado de fenilalanina e seus intermediários - Google Patents

Processo para preparação de um derivado de fenilalanina e seus intermediários

Info

Publication number
BR0308027A
BR0308027A BR0308027-7A BR0308027A BR0308027A BR 0308027 A BR0308027 A BR 0308027A BR 0308027 A BR0308027 A BR 0308027A BR 0308027 A BR0308027 A BR 0308027A
Authority
BR
Brazil
Prior art keywords
preparing
phenylalanine derivative
intermediates
halogen atom
group
Prior art date
Application number
BR0308027-7A
Other languages
English (en)
Inventor
Isao Inoue
Toru Kuroda
Ryuzo Yoshioka
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of BR0308027A publication Critical patent/BR0308027A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"PROCESSO PARA PREPARAçãO DE UM DERIVADO DE FENILALANINA E SEUS INTERMEDIáRIOS". A presente invenção refere-se a um processo para preparação de um novo derivado de fenilalanina de fórmula (I), na qual X^ 1^ é um átomo de halogênio, X^ 2^ é um átomo de halogênio, Q é um grupo de fórmula -CH~ 2~- ou -(CH~ 2~)~ 2~- e y é um grupo alquila inferior, ou um sal farmaceuticamente aceitável do mesmo, que tem excelente atividade inibitória contra adesão celular mediada por integrina <244>4, e um intermediário útil no processo.
BR0308027-7A 2002-02-28 2003-02-27 Processo para preparação de um derivado de fenilalanina e seus intermediários BR0308027A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002052605 2002-02-28
PCT/JP2003/002181 WO2003072536A1 (en) 2002-02-28 2003-02-27 A process for preparing a phenylalanine derivative and intermediates thereof

Publications (1)

Publication Number Publication Date
BR0308027A true BR0308027A (pt) 2004-12-28

Family

ID=27764341

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308027-7A BR0308027A (pt) 2002-02-28 2003-02-27 Processo para preparação de um derivado de fenilalanina e seus intermediários

Country Status (22)

Country Link
US (1) US7476758B2 (pt)
EP (1) EP1478619B1 (pt)
KR (1) KR100681224B1 (pt)
CN (2) CN100480233C (pt)
AR (1) AR038624A1 (pt)
AT (1) ATE495147T1 (pt)
AU (1) AU2003208618B2 (pt)
BR (1) BR0308027A (pt)
CA (1) CA2476022C (pt)
DE (1) DE60335704D1 (pt)
ES (1) ES2359302T3 (pt)
HK (1) HK1069382A1 (pt)
IL (1) IL163429A (pt)
MX (1) MXPA04008359A (pt)
MY (1) MY140707A (pt)
NO (1) NO331001B1 (pt)
NZ (1) NZ534957A (pt)
PL (1) PL211046B1 (pt)
RU (1) RU2280641C2 (pt)
TW (1) TWI327996B (pt)
WO (1) WO2003072536A1 (pt)
ZA (1) ZA200406747B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI312347B (en) 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
EP1389618B1 (en) 2001-04-27 2011-06-15 Eisai R&D Management Co., Ltd. Pyrazolo 1,5-a pyridines and medicines containing the same
AU2003265398A1 (en) * 2002-08-09 2004-02-25 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
AU2003275589B2 (en) * 2002-10-22 2009-05-28 Eisai R & D Management Co., Ltd. 7-phenyl pyrazolopyridine compounds
US7176216B2 (en) 2002-10-22 2007-02-13 Eisai Co., Ltd. 7-phenylpyrazolopyridine compounds
US7501538B2 (en) * 2003-08-08 2009-03-10 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions and methods of use
US7208601B2 (en) * 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
WO2006131200A1 (en) 2005-06-09 2006-12-14 Ucb Pharma, S.A. 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament
CA2721670C (en) 2008-04-15 2013-09-10 Eisai R&D Management Co., Ltd. 3-phenylpyrazolo[5,1-b]thiazole compound
AR078521A1 (es) 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
WO2011048091A1 (en) * 2009-10-21 2011-04-28 Glaxo Group Limited Process for preparing a phenylalanine derivative
WO2020092394A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
AU2019373245C1 (en) 2018-10-30 2022-10-27 Gilead Sciences, Inc. Compounds for inhibition of alpha 4β7 integrin
CA3115820A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. Compounds for inhibition of .alpha.4.beta.7 integrin
KR20240015737A (ko) 2018-10-30 2024-02-05 길리애드 사이언시즈, 인코포레이티드 알파4베타7 인테그린 억제제로서의 퀴놀린 유도체
US11578069B2 (en) 2019-08-14 2023-02-14 Gilead Sciences, Inc. Compounds for inhibition of α4 β7 integrin

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508251A1 (de) 1985-03-08 1986-09-11 Merck Patent Gmbh, 6100 Darmstadt Dipeptide
GB8625941D0 (en) 1986-10-30 1986-12-03 Sandoz Ltd Substituted alpha-amino acids
NZ228855A (en) 1988-04-25 1992-08-26 Hoffmann La Roche Tyrosine analogues and peptides containing them especially cholecystokinin (cck) analogues
JP2868914B2 (ja) 1991-03-04 1999-03-10 日本ケミファ株式会社 α−アミノ酸誘導体
US5294632A (en) 1991-05-01 1994-03-15 Ciba-Geigy Corporation Phosphono/biaryl substituted dipetide derivatives
US5455260A (en) 1993-05-21 1995-10-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aliphatic amino bis-aryl squalene synthase inhibitors
EP0728145A1 (en) 1993-11-01 1996-08-28 Ciba-Geigy Japan Limited Endothelin receptor antagonists
US5432186A (en) 1993-11-16 1995-07-11 Ciba-Geigy Corporation Cyclic amino acid derivatives
IL112759A0 (en) 1994-02-25 1995-05-26 Khepri Pharmaceuticals Inc Novel cysteine protease inhibitors
AU694495B2 (en) 1994-03-28 1998-07-23 Ciba-Geigy Japan Limited Antagonists of endothelin receptors
US5505244A (en) * 1994-08-08 1996-04-09 Thumann; Pierce A. Retractable covering for a door opening
EP0798291B1 (en) 1994-12-14 2002-09-11 Santen Pharmaceutical Co., Ltd. Novel 1,3-dialkylurea derivatives
US6306840B1 (en) 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
US5977075A (en) 1995-04-21 1999-11-02 Novartis Ag N-aroylamino acid amides as endothelin inhibitors
GB9518553D0 (en) 1995-09-11 1995-11-08 Fujisawa Pharmaceutical Co New urea derivatives processes for the preparation thereof and pharmaceutical composition comprising the same
JPH0987291A (ja) 1995-09-26 1997-03-31 Wakamoto Pharmaceut Co Ltd 新規なアラニン誘導体
JPH11512702A (ja) 1995-09-28 1999-11-02 日本チバガイギー株式会社 エンドセリンレセプターのアンタゴニスト
IT1277737B1 (it) 1995-12-28 1997-11-12 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
US5849293A (en) * 1996-01-11 1998-12-15 Cornell Research Foundation, Inc. Use of human transferrin in controlling insulin levels
FR2745571B1 (fr) 1996-03-04 1998-06-19 Inst Nat Sante Rech Med Nouveaux derives soufres comportant une liaison amide, leur procede de preparation, leur application a titre de medicaments, et les compositions pharmaceutiques les renfermant
WO1997040065A2 (en) 1996-04-24 1997-10-30 Peptide Therapeutics Limited Substrates and inhibitors of proteolytic enzymes
JPH1036587A (ja) * 1996-07-24 1998-02-10 Chisso Corp 二軸延伸ポリプロピレンフィルム
SE9700934D0 (sv) * 1997-03-14 1997-03-14 Astra Ab New formulation
JP2002512625A (ja) 1997-05-29 2002-04-23 メルク エンド カンパニー インコーポレーテッド 細胞接着阻害薬としての複素環アミド化合物
US6221888B1 (en) 1997-05-29 2001-04-24 Merck & Co., Inc. Sulfonamides as cell adhesion inhibitors
US6291511B1 (en) 1997-05-29 2001-09-18 Merck & Co., Inc. Biarylalkanoic acids as cell adhesion inhibitors
JP2002501518A (ja) 1997-05-30 2002-01-15 セルテック セラピューティックス リミテッド 抗炎症性チロシン誘導体
US6127341A (en) 1997-06-20 2000-10-03 Novo Nordisk A/S Compounds with growth hormone releasing properties
ES2206953T3 (es) 1997-06-23 2004-05-16 Tanabe Seiyaku Co., Ltd. Inhibidores de la adherencia celular mediada por alfa 4-beta 1.
CN1265670A (zh) 1997-07-31 2000-09-06 伊兰药品公司 抑制vla－4介导的白细胞粘附的二肽和相关的化合物
CN1265669A (zh) 1997-07-31 2000-09-06 伊兰药品公司 抑制由vla－4介导的白细胞粘着的化合物
EP0994895A1 (en) 1997-07-31 2000-04-26 Elan Pharmaceuticals, Inc. Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4
WO1999006436A1 (en) 1997-07-31 1999-02-11 Elan Pharmaceuticals, Inc. Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4
US6489300B1 (en) 1997-07-31 2002-12-03 Eugene D. Thorsett Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
CN1133648C (zh) 1997-07-31 2004-01-07 伊兰药品公司 抑制vla-4介导的白细胞粘附的取代的苯丙氨酸型化合物
AR016133A1 (es) 1997-07-31 2001-06-20 Wyeth Corp Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria
PL338413A1 (en) 1997-07-31 2000-11-06 Elan Pharm Inc Compound of 4-amino phenylalanine type inhibiting adhesion of leucocytes through the meditation of vla-4
US6229011B1 (en) 1997-08-22 2001-05-08 Hoffman-La Roche Inc. N-aroylphenylalanine derivative VCAM-1 inhibitors
US6455550B1 (en) 1997-08-22 2002-09-24 Hoffmann-La Roche Inc. N-alkanoylphenylalanine derivatives
US5988980A (en) * 1997-09-08 1999-11-23 General Electric Company Blade assembly with splitter shroud
US6069163A (en) 1997-10-21 2000-05-30 Merck & Co., Inc. Azapeptide acids as cell adhesion inhibitors
US6191171B1 (en) 1997-11-20 2001-02-20 Merck & Co., Inc. Para-aminomethylaryl carboxamide derivatives
US6090841A (en) 1997-11-21 2000-07-18 Merck & Co., Inc. Substituted pyrrole derivatives as cell adhesion inhibitors
US6645939B1 (en) 1997-11-24 2003-11-11 Merck & Co., Inc. Substituted β-alanine derivatives as cell adhesion inhibitors
AU750175B2 (en) 1997-11-24 2002-07-11 Merck & Co., Inc. Cyclic amino acid derivatives as cell adhesion inhibitors
US6197794B1 (en) 1998-01-08 2001-03-06 Celltech Therapeutics Limited Phenylalanine derivatives
EP1050525B1 (en) 1998-01-19 2005-08-31 Takara Bio Inc. Substances capable of inducing apoptosis
MY153569A (en) * 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
US6555562B1 (en) 1998-02-26 2003-04-29 Celltech R&D Limited Phenylalanine derivatives
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9812088D0 (en) 1998-06-05 1998-08-05 Celltech Therapeutics Ltd Chemical compounds
AU8059598A (en) 1998-06-11 1999-12-30 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
US6685617B1 (en) 1998-06-23 2004-02-03 Pharmacia & Upjohn Company Inhibitors of α4β1 mediated cell adhesion
NL1009753C2 (nl) 1998-07-28 2000-02-01 Royalty Bugaboo S A R L Buggy.
EP1144365B1 (en) 1998-12-22 2004-03-17 Tanabe Seiyaku Co., Ltd. Inhibitors of alpha-4 beta-1 mediated cell adhesion
AU2623900A (en) 1999-01-22 2000-08-07 American Home Products Corporation Compounds which inhibit leukocyte adhesion mediated by vla-4
GB2354440A (en) 1999-07-20 2001-03-28 Merck & Co Inc Aryl amides as cell adhesion inhibitors
WO2001012183A1 (en) 1999-08-16 2001-02-22 Merck & Co., Inc. Heterocycle amides as cell adhesion inhibitors
AU6909300A (en) 1999-08-20 2001-03-19 Merck & Co., Inc. Substituted ureas as cell adhesion inhibitors
EP1214292B1 (en) 1999-09-24 2007-06-13 Genentech, Inc. Tyrosine derivatives
MY129000A (en) * 2000-08-31 2007-03-30 Tanabe Seiyaku Co INHIBITORS OF a4 MEDIATED CELL ADHESION
US6489511B1 (en) * 2001-08-16 2002-12-03 Eastman Kodak Company Azomethine compound manufacture

Also Published As

Publication number Publication date
NO331001B1 (no) 2011-09-05
CA2476022A1 (en) 2003-09-04
TWI327996B (en) 2010-08-01
US20050165107A1 (en) 2005-07-28
IL163429A (en) 2012-07-31
CN100522930C (zh) 2009-08-05
ZA200406747B (en) 2005-08-31
NO20044087L (no) 2004-09-27
CA2476022C (en) 2008-07-15
PL211046B1 (pl) 2012-04-30
TW200303854A (en) 2003-09-16
CN1646482A (zh) 2005-07-27
RU2280641C2 (ru) 2006-07-27
AR038624A1 (es) 2005-01-19
CN1817853A (zh) 2006-08-16
MXPA04008359A (es) 2004-11-26
RU2004128935A (ru) 2006-02-20
ATE495147T1 (de) 2011-01-15
KR100681224B1 (ko) 2007-02-09
PL371386A1 (en) 2005-06-13
EP1478619A1 (en) 2004-11-24
HK1069382A1 (en) 2005-05-20
US7476758B2 (en) 2009-01-13
EP1478619B1 (en) 2011-01-12
AU2003208618A1 (en) 2003-09-09
DE60335704D1 (de) 2011-02-24
KR20040091665A (ko) 2004-10-28
CN100480233C (zh) 2009-04-22
ES2359302T3 (es) 2011-05-20
AU2003208618B2 (en) 2008-06-19
NZ534957A (en) 2006-11-30
WO2003072536A1 (en) 2003-09-04
MY140707A (en) 2010-01-15

Similar Documents

Publication Publication Date Title
BR0308027A (pt) Processo para preparação de um derivado de fenilalanina e seus intermediários
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
BR0009297A (pt) Composto, processo para produzir o mesmo,composição farmacêutica, método paraantagonizar hormÈnio de liberação degonadotropina em um mamìfero, e, uso de umcomposto
WO2001014330A3 (en) Phenylpiperazines as serotonin reuptake inhibitors
CA2405486A1 (fr) Procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
TW200800974A (en) Glucuronate salt of a piperazine compound
AU2003257493A1 (en) Pleuromutilin derivatives as antimicrobbials
BR0012489A (pt) Composto, composição farmacêutica, uso de um composto, e, kit para a contracepção masculina
TW200609223A (en) Process for the preparation of n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives
PT865498E (pt) Processo para a preparacao de ciclodepsipeptideos com 24 atomos no anel substituidos contendo acido aril-lactico
MY129831A (en) Process for preparing aripiprazole
BR9810657A (pt) &#34;processo de preparação de um per-hidroisoindol substituìdo&#34;
MA27143A1 (fr) Utilisation de derives de 2-amino-4- pyridylmethyl-thiazoline comme inhibiteurs de no-synthase inductible
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
PT1303514E (pt) Processo para preparacao de azacicloalcanoilaminotiazoles
PT1102765E (pt) Processo para a sintese de derivados de (1h)-benzo¬c|quinolizin-3-onas
BR9911794A (pt) Derivados anti-histamìnicos de piperidina e intermediários para a preparação dos mesmos
PT1210359E (pt) Processo para a preparacao de derivados do acido 3-amino-biliar
BR9810896A (pt) Processo de preparação de derivados aminas de alquiloxifuranona, compostos provenientes desse processo e utilização desses compostos
DK1347965T3 (da) Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf
PT1347960E (pt) Processo para a preparacao de (+)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperidina
BR0212839A (pt) Derivados de alquilaminopiridazinona substituìdos, processo para a preparação destes e composição farmacêutica contendo os mesmos
PT1230252E (pt) Derivados de beta-d-5-tioxilose processo de preparacao e utilizacao em terapeutica
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
BR9911445A (pt) Derivados de propenil cefalosporina

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: MITSUBISHI TANABE PHARMA CORPORATION (JP)

Free format text: ALTERADO DE: TANABE SEIYAKU CO., LTD.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2364 DE 26-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.